http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002500200-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate | 1998-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002500200-A |
| titleOfInvention | Topical ophthalmic remedies including immunosuppressants |
| abstract | (57) [Summary]nA therapeutic agent for topical ophthalmic treatment, comprising 0.02 to 5.0% by weight of an immunosuppressant belonging to the group consisting of monocyclic undecapeptides, macrolide lactones or corticosteroids, It is a therapeutic agent containing up to 10% by weight of a polyalkylene glycol-polyurethane copolymer as an agent. In the case of a hydrophilic base, the polyalkylene glycol-polyurethane copolymer comprises poly (oxy-1,2-ethanediyl) -α-hydro-ω-hydroxy polymer and 1,1′-methylene-bis- (4-isocyanate). And a copolymer having a weight average molecular weight of 1,000 to 3,000, and in the case of a lipophilic base, polyalkylene glycol-polyurethane copolymer is preferably poly [oxy (methyl-1,2-ethanediyl). )] It is preferable to comprise a copolymer of -α-hydro-ω-hydroxy polymer and 1,1′-methylene-bis- (4-isocyanatocyclohexane) having a weight average molecular weight of 1600 to 18000. The therapeutic agent may further include a common excipient in a topical administration form. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007518690-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006511475-A |
| priorityDate | 1997-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.